Why Intelligent Design Is Powering Energy Evolution

 

Joe Piccirilli, Managing Director at RoseWater Energy Group, has always spoken about four pillars of energy design: perfect power quality, protection against lightning, battery backup and renewable integration. Now, he’s added a fifth.

“After a few years of dealing with misconceptions about what batteries and renewals are capable of doing, I’ve added a fifth pillar,” he said. “That fifth pillar is intelligent design.”

For instance, a number of people who Troy Morgan CEO of PantTech Design, has worked with recently think they can power their whole house on battery backup for nearly an endless amount of time. Others think if they have solar panels, their house will stay powered even if the grid goes down. Not so – unless a battery is involved.

That’s why Morgan and Piccirilli think educating the public on energy issues is so important. That includes consumers who simply want to make sure their power stays on at their home, but also builders and contractors responsible for designing the systems

“The traditional design principles have required contractors to pre-define (a complicated energy plan), know all this up front and then, more importantly, design the system in such a way that there’s a separate energy panel that the battery powers. So, all the things the battery powers go in that and everything else is in a completely separate load center,” he said. “With Adapt Energy, you don’t have to think about it like that anymore, but you do still have to know up front what can the battery power and what can’t the battery power.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More